CLOs on the Move

Central Georgia Health Network

www.mycghn.com

 
CGHN has been a trusted partner for Central Georgia independent physicians for over 20 years, with proven success in favorable payouts, dividends and contracting. This commitment to physician independence is at the very heart of CGHN`s identity. CGHN`s ownership structure ensures independent physicians in Central Georgia maintain a strong, controlling governance voice. CGHN is a growing, clinically-integrated network representing nearly 1,000 independent physicians, healthcare professionals and hospital partners across Central Georgia. Our goal is to deliver the best patient care experiences, while enhancing care quality and lowering costs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mycghn.com
  • 111 Perimeter Parkway
    Macon, GA USA 31210
  • Phone: 478.832.6134

Executives

Name Title Contact Details

Similar Companies

OKC-County Health Department

The OKC-County Health Department serves the residents of Oklahoma County by promoting and protecting health, preventing disease, and creating partnerships.

Medical Professionals

Medical Professionals is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Capital City Nurses

Capital City Nurses is a Chevy Chase, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PanOptica

At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.

Avid Radiopharmaceuticals Inc

Avid Radiopharmaceuticals Inc is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.